Eyeworld

by Title ASCRS NEWS Heading Name title Contact Name: email 14 | EYEWORLD | SPRING 2026 Important Product Information for LenSx™ Laser system Caution: Federal Law restricts this device to sale and use by or on the order of a physician or licensed eye care practitioner. INDICATIONS FOR THE LENSX™ LASER (FOR ADULT PATIENTS): In the creation of corneal cuts/incisions (single-plane, multiplane and arcuate) anterior capsulotomy and laser phacofragmentation during cataract surgery. Each of these procedures may be performed either individually or consecutively during the same surgery. In the creation of corneal cuts/incisions (single-plane, multi- plane, and arcuate) during Implantable Collamer Lens (ICL) surgery. In the creation of a corneal flap for patients undergoing LASIK surgery or other treatment requiring initial lamellar resection of the cornea. In the creation of corneal pockets for placement/insertion of a corneal inlay device; and for creation of corneal tunnels for the placement of corneal rings. CONTRAINDICATIONS: Conditions that would interfere with transmission of laser light at 1030 nm wavelength including presence of material or opacities anterior to or at laser plane. Examples include, but are not limited to: Corneal opacity, Corneal lesions, Corneal edema, Existing corneal implants, Blood or other material in the anterior chamber. Conditions that preclude safe applanation of the cornea, which include, but are not limited to: descemetocele with impending corneal rupture, existing corneal implants, hypotony, and glaucoma (glaucoma is not contraindicated with use of SoftFit ® Patient Interface). Previous corneal incisions that might provide a potential space into which the gas produced by the procedure can escape. Residual, recurrent, active ocular or eyelid disease, including any corneal abnormality. Examples of corneal abnormality include, but are not limited to: corneal ectasia, recurrent corneal erosion, severe basement membrane disease. This device is contraindicated in pediatrics. Flap creation, tunnels, pockets, and cataract procedures cannot be combined into a single treatment. In addition to the above system contraindications, cataract surgery only contraindications include, but are not limited to: poorly dilating pupil, such that the iris is not at least 0.1 mm peripheral to the intended capsulotomy treatment at any point, i.e. the pupil diameter should be at least 0.2 mm larger than the capsulotomy diameter. Conditions which would cause inadequate clearance between any capsulotomy laser treatment and the corneal endothelium (applicable to capsulotomy only). Corneal thickness requirements that are beyond the range of the system. A history of lens instability or zonular dehiscence such that the lens is grossly decentered or unable to maintain its position during treatment. Any contraindications to cataract surgery. WARNINGS: The LenSx™ Laser System should only be operated by a physician trained in its use. The LenSx™ Laser delivery system employs one sterile disposable Patient Interface consisting of an applanation lens and suction ring. Use of disposables other than those manufactured by Alcon may affect system performance and create potential hazards. COMPLICATIONS: As with any surgical procedure, risk is involved. The following potential complications pose risks resulting from anterior capsulotomy, phacofragmentation, or creation of a partial thickness or full-thickness cut or incision as well as corneal procedures such as the creation of flap, tunnel or pocket: corneal edema, corneal decompensation, and subsequent severe loss of visual acuity, capsular tissue damage, corneal abrasion and epithelial defect, pain, electrical shock to non- patient and electrical shock to patient, bleeding, damage to ocular and non-ocular structures such as: iris damage due to trauma, physical injury to the patient and/or operator, corneal endothelial cell loss, and tissue damage not otherwise specified which includes complications during the procedure leading to incomplete or decentered flap and/or injury at the incision site posing a risk for wound leakage and subsequent inflammation and/or infection that could result in corneal opacity, Elevated IOP that may require additional intervention. Attention: Refer to the LenSx™ Laser Operator's Manual for a complete listing of indications, warnings and precautions. © 2026 Alcon Inc. 01/26 US-LSX-2600001 gained from academic and trade journals alone. Network- ing strengthens referral relationships, encourages collab- oration, and opens doors for leadership and mentorship opportunities. The Annual Meeting also reinforces profes- sional identity, shared standards, philanthropy, and advoca- cy. Engaging in discussions about ethics, policy, reimburse- ment, and activism ensures we surgeons help shape the future of our specialty rather than react to it. Ultimately, attendance and participation demonstrate commitment to lifelong learning, collegiality, and achieving the highest level of patient care. The ASCRS staff and leadership are looking forward to seeing you in lovely Washington, D.C., in just a few short weeks. In this issue of EyeWorld, we highlight how modern ophthalmology is rapidly evolving toward personalized, technology-guided care. Accurate diagnostics—topog- raphy, keratometry alignment, and careful exams—are critical for successful cataract and refractive outcomes. New therapeutic frontiers include biologic drugs targeting cellular pathways and suprachoroidal procedures offering alternative glaucoma treatment routes. Patient comfort and efficiency are also improving through oral sedation tech- niques. Ophthalmology training must therefore emphasize strong fundamentals while incorporating emerging devices and surgical methods. Overall, the field is shifting from standardized surgery to individualized treatment, where imaging, biomolecular therapies, and adjustable technolo- gies work together to maximize vision quality, safety, and patient satisfaction. I would like to congratulate Francis Mah, MD, on a productive year as ASCRS President. The year was not without its challenges for us as an organization, but Fran- cis' steady and calm leadership proved to be key to leading us to reclaim a strong foundation and improved transpar- ency across many facets of our organization. At the Annual Meeting, we will welcome Kevin M. Miller, MD, as our new ASCRS President. Dr. Miller is chief of the cataract service at UCLA and a prolific researcher, educator, and innovator, advancing modern anterior segment and refractive surgery worldwide. Lastly, my term as Chief Medical Editor of EyeWorld is up. I would like to thank the dedicated staff of EyeWorld and ASCRS for all their support during my term. This publication and organization would not be possible with- out their hard work and commitment. I welcome Mitchell Weikert, MD, as the next Chief Medical Editor of EyeWorld. Mitch is a dear friend and well-respected anterior segment surgeon. I know his insights and leadership will be great for this publication and our organization. As always, if you have any suggestions for topics, improvements, etc., please feel free to reach out to me at gargs@uci.edu. I look forward to seeing you all at our Annual Meeting in Washington, D.C. continued from page 3

• Cover